长春高新：公司会持续跟进各研发管线的进展、竞争力、技术先进性、持续研发成功可能性等情况

Core Viewpoint - The company emphasizes that drug development is a high-investment, long-term, and high-risk process, and it will continuously monitor the progress of its research pipelines and make informed decisions regarding their continuation or cessation based on various factors [1] Group 1 - The company is committed to tracking the progress of its research pipelines [1] - The company will assess the competitiveness and technological advancement of its projects [1] - The company will evaluate the likelihood of continued success in research and development [1]